The bicuspid aortic valve (BAV) is associated with various cardiovascular malformations, most predominantly with dilatation of the aortic root and ascending aorta. After sporadic observations of various BAV-associated mitral valve pathologies, we sought to systematically examine the mitral valve morphology in patients with a BAV.
INTRODUCTION
The bicuspid aortic valve (BAV) is the most frequent cardiovascular malformation, presenting in 0.46-1.37% of the population [1] . Although initially thought of as a benign entity, clinical research has shown that patients with a BAV have a higher incidence of aortic valve disease or dilatation of the aortic root or ascending aorta mandating surgical intervention. Recently published clinical guidelines have recognized the increased incidence of thoracic aortic complications in patients with a BAV presenting with dilated thoracic aorta, to justify a more aggressive approach [2, 3] . There is now growing evidence of pathological characteristics in the ascending aorta of patients with a BAV, such as histological abnormalities, decreased elasticity, enlarged diameters and increased growth rate. However, the complete spectrum of BAV-associated cardiovascular abnormalities remains unknown.
From our experience, we have observed that some patients with a BAV referred for surgical intervention in the aortic valve or root often present with a characteristic finding of a disproportionally elongated, 'hypermobile' anterior (or 'aortic' [4] ) leaflet of the mitral valve (AML) [5] . To our knowledge, there is no systematic investigation of the mitral valve dimensions in patients with a BAV.
PATIENTS AND METHODS

Study population
Between 2007 and 2010, all patients with a BAV requiring surgical intervention underwent a standardized echocardiographic examination with concomitant evaluation of the mitral valve. All patients provided written consent for data acquisition and use. To reduce complexity, we focused on the most often encountered BAV phenotype type 1 L/R: one raphe between the left and right coronary leaflet [6] (Fig. 1) , which seems to have a distinct developmental background compared with other BAV phenotypes [7, 8] . Patients with either regurgitation or stenosis were analysed; however, patients with documented or clinical suspicion of Marfan syndrome or aortic dissection were excluded. Forty-four patients with echocardiographic as well as intraoperatively documented BAV type 1 L/R were identified and were included in the present study. Forty patients with tricuspid aortic valves (TAVs) operated on during the same time period, as well as 20 healthy adults, served as controls (Normal). The preoperative as well as operative characteristics of the patient collective are displayed in Table 1 .
Measurement acquisition
All transthoracic echocardiographic examinations were performed by one investigator (U.S.) with the same equipment (Vivid 7, General Electric Medical Systems, WI, USA). The mitral valve annulus (MA) was measured at the maximum diameter between the A2-P2 segments as obtained in the four-chamber view during mid-to end-diastole, and just before the beginning of the mitral leaflet closure movement. Similarly, the height of the AML was measured at its maximum height (height of the A2 segment from the hinge point to the tip of the leaflet) as obtained in the four-chamber view during diastole. For every value, three measurements were obtained, the average of which was included in the analysis. The MA diameter was evaluated at the A2-P2 level, as this was the most reproducible measurement obtained with transthoracic echocardiography in all patients.
Statistical analysis
All data are presented as mean ± 1 SD. Student's t-test as well as ANOVA methods was employed to explore and compare differences in variables between the groups and subgroups, allowing for multiple testing corrections (Bonferroni correction for multiple comparisons). Linear regression analyses were performed to explore the relations between measurements and preoperative characteristics, as well as to identify group effects. To restore normality of the AML and MA measurements, the natural log transformation of these measurements was entered in the linear regression model. The following factors were included in the models: age, weight, height, BSA, group (BAV, TAV, Normal), predominant haemodynamics (AS: aortic stenosis; AR: aortic regurgitation), MA diameter. Statistical significance was indicated by a P-value <0.05. The conditional probabilities of aortic phenotype (BAV, TAV, Normal) given AML heights (Fig. 2D) were calculated using smoothing via kernel density approaches. Statistical analyses were performed using R [version 2. Table 1 presents the patients' preoperative characteristics, functional preoperative echocardiographic data, operative data as well as preoperative echocardiographic measurements of the aortic root and the mitral valve in the five subgroups. Patients with a BAV were significantly younger and taller than patients with a TAV. No difference could be observed in terms of the severity of regurgitation or stenosis between BAV or TAV groups and subgroups. Patients with a BAV had a significantly elongated anterior mitral leaflet (AML) than patients in the TAV or Normal groups (33.2 ± 6.6, 27.7 ± 3.2, 27.0 ± 1.9 mm respectively; P < 0.001). The MA diameter was larger in BAV than in TAV or Normal (37.0 ± 4.9, 33.7 ± 6.4, 28.2 ± 1.9 mm respectively; P < 0.005). A statistically significant correlation could be observed between the patients' height and the height of the AML. The AML height tends to increase with increases in patient's height; however, patients with a BAV had, on average, 20% larger AML than patients with a TAV, irrespective of the patients' height (P = 0.001) (Fig. 2B) . When allowing for the MA diameter and patients' height, patients with a BAV had, on average, 11.2% larger AML (P = 0.0005), irrespective of the patients' height or MA diameter (Fig. 2A) . Moreover, patients with a BAV and AR had, on average, 15% larger AML than the other groups (P < 0.001), irrespective of the MA diameter or the patient's height (Fig. 2C) .
RESULTS
The distribution of the AML height measurements was fundamentally different in the BAV, TAV and Normal groups. The Normal and TAV groups have similar AML height distributions (range: 24-30 and 22-35 mm, respectively); however, the BAV group dominated the AML height >35 mm (median: 32 mm, range: 23-58) and had a very small representation in AML height <30 mm. An AML height of >32 mm in the patients undergoing aortic valve/root surgery was highly predictive of the presence of a BAV [specificity: 90%, positive predictive value: 82%, area under curve: 0.80 (95% CI: 0.71-0.88)] (Fig. 2D ).
DISCUSSION
In this study, we provide evidence that the anterior leaflet of the mitral valve is elongated in patients with a BAV compared with patients with a TAV or individuals without cardiovascular manifestations. No difference could be observed between patients with a TAV and normal individuals. This effect is more prominent in patients with a BAV and with concomitant clinically significant aortic regurgitation.
The most frequent and clinically relevant BAV-associated cardiovascular malformation is the dilatation of the ascending aorta, which typically presents in four clusters [9] . Although the dilatation process was initially thought to be the result of flow alterations caused by the diseased valve, root dilatation has also been demonstrated in BAV without significant gradients or regurgitation [10] . Furthermore, many patients with a BAV have severe stenosis and normal-sized ascending aortas. On the other hand, it has been reported that the complete thoracic aorta can be enlarged in some patients with a BAV. Thus, there is growing evidence that dilatation of the thoracic aorta may be genetically determined and probably modulated by haemodynamic factors [11] . Interestingly, the largest AML diameters were found in BAV with significant regurgitation, which is in concordance with the recently reported, most extensive form of 'BAV associated inand outflow dilatative malformations', including the dilatation of the ascending aorta, namely the WAMBIRE complex (Weak Aorto-Mitral BIcuspid RElation) [5] . Evidence is growing that especially regurgitant BAVs are associated with some kind of connective tissue weakening in the cardiovascular system. This might explain the presence of abnormalities in areas other than downstream of the aortic valve, for example the pulmonary artery [12] .
There is some evidence that the mitral valve is not only enlarged in BAV but may degenerate over time in a myxomatous fashion, eventually mandating surgical correction in a subset of patients. Lad et al. [13] reported on 29 patients with a BAV who needed a mitral repair or replacement due to degenerative disease. In these patients, the aortic annulus was also enlarged, supporting the phenotypic alterations found in the WAMBIRE complex. Recently, there is a trend to repair these insufficient aortic valves mainly by correcting the prolapsing, fused leaflets. Whether the whole complex of the enlarged root should be more aggressively addressed is not clear and may become a focus of clinical research in the future. In conclusion, our data suggest that in patients with the most frequent phenotype of BAV, the type I L/ R, the anterior leaflet of the mitral valve is enlarged especially in patients with concomitant clinically significant aortic regurgitation. This adds a new morphological characteristic to the BAV-associated malformation spectrum. This finding may be of interest for further genetic and clinical investigations.
